Ubbink, R. http://orcid.org/0000-0003-0005-0502
Wefers Bettink, M. A. http://orcid.org/0000-0001-8094-6389
van Weteringen, W. http://orcid.org/0000-0003-2667-3169
Mik, E. G.
Funding for this research was provided by:
University Medical Center Rotterdam
Article History
Received: 1 April 2020
Accepted: 1 October 2020
First Online: 21 October 2020
Compliance with ethical standards
:
: R. Ubbink: The author is shareholder of Photonics Healthcare, a company aimed at making the delayed fluorescence lifetime technology available to a broad public. Photonics Healthcare B.V. holds the exclusive licenses to several patents regarding this technology, filed and owned by the Academic Medical Center in Amsterdam and Erasmus Medical Center in Rotterdam, The Netherlands. E. G. Mik: The author is a one of the founders and shareholder of Photonics Healthcare, a company aimed at making the delayed fluorescence lifetime technology available to a broad public. Photonics Healthcare B.V. holds the exclusive licenses to several patents regarding this technology, filed and owned by the Academic Medical Center in Amsterdam and Erasmus Medical Center in Rotterdam, The Netherlands. M.A. Wefers Bettink and W. van Weteringen have no conflict of interest to disclose.
: Participants provided informed consent prior to participation.
: Participants consented for publication of the anonymized data.
: The study was approved by the institutional medical ethical committee and registered on ExternalRef removed [NL61767.078.17]. The study complies with the Helsinki declaration on research ethics.